Search - tctmd.com

Displaying 581 - 600 of 870

Sort: Relevancy | Date

Presentation SIF 2017

Critical Decision Making in STEMI PCI

Presenter: Timothy D. Henry

March 09, 2017

Presentation SIF 2017

Intraprocedural Decision Making: How Many Clips Do I Need?

Presenter: Ramon Quesada

March 09, 2017

Presentation ISET 2017

Imaging of Acute Stroke: What You Need to Make a Decision to Treat

Presenter: Kevin Abrams

February 04, 2017

Presentation TCT 2016

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

Presenter: Martin W. Bergmann, Samir R. Kapadia, Vivek Y. Reddy

November 01, 2016

Presentation TCT 2016

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Presenter: Martin W. Bergmann, Samir R. Kapadia, Harvey D. White

November 01, 2016

Presentation TCT 2016

Surveying the Global Landscape of TAVR Newcomers

Presenter: Ganesh Manoharan, Hendrik Treede, Martin B. Leon

November 01, 2016

Presentation TCT 2016

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Presenter: Martin W. Bergmann, Samir R. Kapadia, Jason H. Rogers

November 01, 2016

Presentation TCT 2016

Xeltis: Design and Clinical Updates

Presenter: Ganesh Manoharan, Hendrik Treede, Christian M. Spaulding

November 01, 2016

Presentation TCT 2016

Centera: Design and Clinical Updates

Presenter: Ganesh Manoharan, Hendrik Treede, Stephen G. Worthley

November 01, 2016

Presentation TCT 2016

Is LAA Closure an Alternative to Triple Therapy for all Patients or Those at High Bleeding Risk? Current Dataset

Presenter: Martin W. Bergmann, Samir R. Kapadia, Brian K. Whisenant

November 01, 2016

Presentation TCT 2016

Venus A Valve: Design and Clinical Updates

Presenter: Ganesh Manoharan, Hendrik Treede, Hasan Jilaihawi

November 01, 2016

Presentation TCT 2016

Why Triple Therapy? Rationale and Potential Role for LAA Closure in the PCI Patient

Presenter: Martin W. Bergmann, Samir R. Kapadia, Ashish Pershad

November 01, 2016

Presentation TCT 2016

Jena Valve: Design and Clinical Updates

Presenter: Ganesh Manoharan, Hendrik Treede

November 01, 2016

Presentation TCT 2016

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status

Presenter: Freek W.A. Verheugt, Pascal Vranckx, Deepak L. Bhatt

November 01, 2016

Presentation TCT 2016

The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI: Design, Rationale, and Status

Presenter: Freek W.A. Verheugt, Pascal Vranckx, Roxana Mehran

November 01, 2016

Presentation TCT 2016

Which Device and Technique for This Patient?

Presenter: Ganesh Manoharan, Hendrik Treede, Tamim Nazif, Torsten P. Vahl

November 01, 2016

Presentation TCT 2016

The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status

Presenter: Freek W.A. Verheugt, Pascal Vranckx

November 01, 2016

Presentation TCT 2016

Balloon Angioplasty Vs Bare Metal Vs Stents Covered Stents: How Do You Make the Decision?

Presenter: John D. Carroll, Thomas J Forbes, Elchanan Bruckheimer

November 01, 2016

Presentation TCT 2016

Very Long Term Outcomes after FFR-Based Decision-Making

Presenter: Nick Curzen, Nils Johnson, Frederik M. Zimmermann

November 01, 2016

Presentation TCT 2016

The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status

Presenter: Freek W.A. Verheugt, Pascal Vranckx, C. Michael Gibson

November 01, 2016

Advertisement

Critical Decision Making in STEMI PCI

Intraprocedural Decision Making: How Many Clips Do I Need?

Imaging of Acute Stroke: What You Need to Make a Decision to Treat

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Surveying the Global Landscape of TAVR Newcomers

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Xeltis: Design and Clinical Updates

Centera: Design and Clinical Updates

Is LAA Closure an Alternative to Triple Therapy for all Patients or Those at High Bleeding Risk? Current Dataset

Venus A Valve: Design and Clinical Updates

Why Triple Therapy? Rationale and Potential Role for LAA Closure in the PCI Patient

Jena Valve: Design and Clinical Updates

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status

The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI: Design, Rationale, and Status

Which Device and Technique for This Patient?

The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status

Balloon Angioplasty Vs Bare Metal Vs Stents Covered Stents: How Do You Make the Decision?

Very Long Term Outcomes after FFR-Based Decision-Making

The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content